MedTech Services and CDMO Exit and M&A Strategy Primer

This white paper outlines the MedTech Services and Contract Development and Manufacturing Organization (CDMO) exit and merger and acquisition (M&A) strategy for founders. It discusses the unique challenges faced by MedTech founders, who often possess deep technical expertise but may lack knowledge in corporate finance and investment dynamics. The document explains the increasing interest of private equity in the MedTech services market, driven by fragmentation and the need for consolidation among service providers. It details the process of preparing for an exit, emphasizing the importance of timing and market conditions. The paper also highlights the factors influencing premium valuations for medical device service providers, including sustainable differentiation and scalability. Additionally, it addresses the complexities of the transaction process, which typically spans 6 to 9 months, and the necessity of careful vetting of potential buyers to ensure the continued growth and stability of the business post-transaction.